Protective Effect of Ganoderma (Lingzhi) on Cardiovascular System

Adv Exp Med Biol. 2019:1182:181-199. doi: 10.1007/978-981-32-9421-9_7.


Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels and include coronary heart diseases, cerebrovascular diseases, rheumatic heart diseases, and other conditions. CVDs are one of the most major causes of morbidity and mortality around the world, taking the lives of 17.9 million people every year. Several investigations have shown the influence of Ganoderma lucidum (G. lucidum, Lingzhi) on some metabolic markers, such as low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), blood pressure, and oxidative damage. G. lucidum potentially reduces the risk of suffering cardiovascular diseases. Some studies found that G. lucidum prevented from heart damage in a variety of disease models, such as streptozotocin (STZ)-induced diabetic, high-fat-diet-induced diabetic, isoprenaline (ISO)-induced myocardial hypertrophy, acute ethanol-induced heart toxicity, and transverse aortic constriction (TAC) models. This chapter summarizes putative preventive and therapeutic effects of G. lucidum on cardiovascular diseases and the potential clinical use of G. lucidum involved in these effects.

Keywords: Antioxidant activity; Atherosclerosis; Diabetic cardiomyopathy; Ganoderma; Hypertension.

Publication types

  • Review

MeSH terms

  • Biological Products / pharmacology*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular System / drug effects*
  • Humans
  • Reishi / chemistry*


  • Biological Products